Introducing Farrah Pulce, Head of Project Management

In today’s blog, we are pleased to introduce Farrah Pulce, Head of Project Management at Antheia. Farrah helps every team across the company stay on track toward our collective goals, and her work played a crucial role in our first commercial delivery of thebaine. We sat down with Farrah to learn more about her background […]
Antheia’s 2024 in Review: A Year Of Collaboration

As we reflect on 2024, it’s been a significant year of collaboration, with every Antheia employee and partner helping us move closer toward our mission of transforming pharmaceutical supply chains and ending essential medicine shortages. No one person, company, or organization can solve a daunting global problem like drug shortages alone, but we have made […]
Antheia Lands $12M with Second BioMaP Deal to Reshape U.S. Pharma

The company was awarded for its ability to outperform conventional manufacturing methods for critical pharmaceutical ingredients and rapidly reach a commercial scale in the U.S.
Antheia Secures Second Project Agreement with the BioMaP-Consortium Valued at up to $12M

Company awarded for its ability to outperform conventional manufacturing methods for critical pharmaceutical ingredients and rapidly reach commercial scale in the U.S.
InnovationRx: Venture Investments Into Biopharma And Medtech Reverse 2-Year Slide

Antheia, which is using fermentation to manufacture drug ingredients that are normally produced agriculturally, announced its first commercial delivery this week.
Antheia Fulfills First Commercial Delivery of Thebaine

Antheia, a pharmaceutical ingredient manufacturer, has delivered its first commercial order of thebaine to a leading pharmaceutical customer.
Antheia’s First Commercial Thebaine Delivery Sets New Standard in Pharmaceutical Biomanufacturing

This first commercial-scale thebaine delivery redefines essential medicine supply chains, supporting biomanufacturing’s future in pharma.
Antheia Marks Corporate Milestone with First Commercial Delivery of Thebaine

Company successfully fulfills its first customer order; continues commercial scale production of thebaine and advances other critical pharmaceutical ingredients.
Brewing Medicines with Synthetic Biology: Antheia’s Christina Smolke on Ending Drug Shortages

In this episode of the Grow Everything Biotech Podcast, Karl and Erum welcome Christina Smolke, CEO of Antheia and Professor at Stanford University, to discuss the rapid changes happening in biotech, particularly focusing on the biohacking community and decentralized science (DCI).
Pharma isn’t ready for OTC Narcan demand

Today’s blog will focus on Narcan, a critical opioid overdose rescue drug that is produced from thebaine, Antheia’s first commercial-scale, biomanufactured pharmaceutical ingredient. Read on for more on recent efforts to make Narcan available over the counter, as well as the challenges and opportunities this policy change presents for the pharma industry.